Astex Pharmaceuticals, Inc.
299 articles with Astex Pharmaceuticals, Inc.
-
SuperGen, Inc. To Present At UBS Global Pharmaceuticals Conference
4/17/2006
-
SuperGen, Inc. Announces 2006 First Quarter Financial Results Webcast
4/13/2006
-
SuperGen, Inc. Announces Results From Combination Study In CLL Published In The Journal Of Clinical Oncology
3/14/2006
-
SuperGen, Inc. To Present At Wedbush Morgan Small Cap Conference
2/24/2006
-
SuperGen, Inc. Reports 2005 Fourth Quarter And Year-End Financial Results
2/24/2006
-
SuperGen, Inc. Announces 2005 Fourth Quarter And Year End Financial Results Webcast
2/21/2006
-
SuperGen, Inc. To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/7/2006
-
SuperGen, Inc. To Acquire Montigen Pharmaceuticals Inc. In A $18 Million Deal
1/27/2006
-
SuperGen, Inc. Announces Withdrawal Of Orathecin(TM) Marketing Authorization Application
1/20/2006
-
MGI Pharma Inc. And SuperGen, Inc. Release: Dacogen(TM) (Decitabine) Injection Complete Response Accepted For Review By U.S. FDA
12/16/2005
-
MGI Pharma Inc. And SuperGen, Inc. Dacogen(TM) (Decitabine) Injection Data Presented At American Society Of Hematology Annual Meeting
12/12/2005
-
SuperGen, Inc. Release: Studies Of Nipent(R) In Combination Cancer Therapies For Treatment Of Chronic Lymphocytic Leukemia And Graft-versus Host Disease (GVHD) Presented At American Society of Hematology Annual Meeting
12/9/2005
-
SuperGen, Inc. To Present At First Albany Capital Annual Growth Conference
12/5/2005
-
SuperGen, Inc. And MGI Pharma Inc., Pull European Drug Application
11/15/2005
-
MGI Pharma Inc. And SuperGen, Inc. Fall On Dacogen Delay
10/27/2005
-
SuperGen, Inc. To Present At C.E. Unterberg, Towbin Life Sciences Conference
10/21/2005
-
SuperGen, Inc. Reports 2005 Third Quarter Financial Results
10/21/2005
-
A Look Back At June In Biotech
7/12/2004
-
SuperGen Drug Posts Mixed Results, Stock Plunges
3/31/2004